13TH CONGRESS OF THE EUROPEAN CROHN’S AND COLITIS ORGANISATION
Reed Messe Wien GmbH #Vienna, AUSTRIA
Currently, we are witnessing major scientific advances in every field of IBD, from understanding the causes of these diseases to milestone developments in diagnostic tools and advanced therapies. The theme for the ECCO Congress 2018 is “Science improving patients’ lives,” devoting special attention to discoveries and innovations that can have an impact on disease management. In the programme for 2018 we will have special sections on early stage disease, paediatric IBD, prediction, novel treatment strategies, diagnosis and management of dysplasia, best perioperative care and other aspects that are essential for returning our patients with IBD to a normal life. Our basic science session will be devoted to considering the evolving concepts of IBD pathogenesis.
In the past, the ECCO Congress attracted more than 6,200 delegates from all over the world, becoming the world’s reference IBD event for the presentation and dissemination of advances in the field. It has become an indispensable event for every scientist and clinician with a focus on IBD. Preceding the main congress, there is a wide offer of educational courses covering basic and advanced topics for physicians, nurses, clinical and basic investigators, and pharmaceutical research.
Besides the core programme, the organisation is fostering meetings of study groups and committees, facilitating dissemination of ongoing research projects supported by the European Commission with ECCO involvement. You will find more on our Congress website (www.ecco-ibd.eu/ecco18).
In 2018, the Congress will be held in the city of Vienna from February 14–17. Vienna has hosted a previous ECCO Congress with great success and is indeed ECCO’s hometown where we have our office and have developed outstanding work for the performance and expansion of the organisation. Vienna is an attractive and lovely city, one of the capitals of European culture, which provides an additional attraction to our meeting.
We hope to meet you in Vienna in February 2018. On behalf of the Organising Committee and the whole ECCO team, I extend a warm welcome to the 13th Congress of ECCO.
ECCO President & Chair of Organising Committee
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
For this year's congress destination, Vienna, hotels ranging from the most elegant and stylish to the very business-like. All the hotels are located either in the city center, along underground line U2, which leads you directly to the congress center or close to the congress venue. Rooms will be assigned on a "first come, first served" basis. Early booking is highly recommended. All room rates are in EUR (Euro), per room and night including breakfast, taxes and service charges.
To make your hotel reservation, please use our online hotel booking system.
For group hotel bookings (10 rooms and more), please contact our housing partner Kuoni Congress directly at firstname.lastname@example.org with your requirements. If you have questions, please feel free to contact Kuoni anytime per email at email@example.com, they are happy to be of assistance!
All mentioned rates are quoted in Euro.
Abstract submission deadline 2017-10-20
The authors should choose one topic only for every abstract submitted. If an abstract fits into more than one of the topics below, choose the most appropriate one.
Topic 1: Basic Science
Topic 2: Clinical: Diagnosis and Outcome
Topic 3: Clinical: Therapy and Observation
Topic 4: Epidemiology
Topic 5: Genetics
Topic 6: Microbiology
Additional topic - “Nurses abstracts”: Nurses may submit their scientific works in the category “Nurses abstracts”. Out of all submitted nurses abstracts, three abstracts will be selected for oral presentation during the 12th N-ECCO Network Meeting and a number of abstracts will be selected for poster presentation.
Abstract rules and regulations
The submitter certifies to be an investigator with a substantial involvement in the study presented in the abstract and having the right to submit and present the study.
The submitter accepts responsibility for the accuracy and scientific content of the submitted abstract (please proofread the abstract carefully prior to submission!)
The submitter accepts to be the contact person for all correspondence about the abstract and to inform co-authors about its status.
The submitter confirms that all co-authors are aware of and agree to the content of the abstract and support the data presented. Furthermore, the submitter will be responsible for obtaining, and, upon request, providing proof that all authors have given permission for the submission of the abstract and agree on its content.
The submitter confirms that the submitted abstract is an original paper and has not been published or presented at an international meeting prior to ECCO’18.
The submitter confirms that the submitted abstract has not been previously published as an article/full paper at the time of submission.
The submitter confirms that the abstract has not been already submitted for ECCO’18 by a co-author.
Statements such as “data will be presented” in the abstracts are likely to lead to rejection of the abstract.
Abstracts that include clinical trial data should follow the CONSORT statement
Any financial interest in products or processes described in the abstract needs to be identified. The submitter is requested to tick the “Conflict of interest” box when submitting the abstract and to provide disclosure of interests and relationships through the abstract submission programme for each author. This includes stock ownership, membership on an advisory board or board of directors, corporate-sponsored research, or other substantive relationships.
When selected for presentation, the copyright of the abstract is released to ECCO and permission is given for the abstract to be published in the JCC Abstract Book 2018, as well as on the ECCO Website and possibly an ECCO mobile application.
Submission of an abstract constitutes a formal commitment by the author to present the abstract in the session and at the time decided upon by the ECCO Organising Committee. Any change in the presenting author needs to be communicated in the form of a written statement to the ECCO Scientific Committee. Failure to present the abstract for other than well-founded reasons will lead to rejection of abstracts submitted at the next ECCO Congress. The registration fees for the presenting author will not be waived.
ECCO will withdraw abstracts upon written notification from the submitting author by the deadline stated in the notification email. After this date, ECCO cannot guarantee that a withdrawn abstract will be excluded from publication. If circumstances prevent attendance, the presenting author must arrange for the presentation to be given by a co-author. Acceptance of the abstract obligates the author to present the paper.
The submitter confirms that copyright permissions for all third-party material (including without limitation textual extracts or illustrations, photographs, maps, diagrams and tables) have been obtained.
In order to ensure the smooth functioning of the official congress activities and optimal attendance by delegates, the following guidelines have been developed.
Codes & compliance
It is the exhibitor’s/sponsor’s responsibility to consult and comply with guidelines and codes of practice applicable to Austria – Pharmig Code of Conduct http://www.pharmig.at
Furthermore, the exhibitors/sponsors must consult and comply with relevant guidelines set forth by EFPIA (European Federation of Pharmaceuticals Industries & Associations) https://www.efpia.eu/, IFPMA (International Federation of Pharmaceuticals Manufacturers & Associations) www.ifpma.org and EUCOMED www.eucomed.be Code of Practice with regard to the promotion of medicines, as well as the regulations of EACCME (The European Accreditation Council for CME) http://www.uems.eu/uems-activities/accreditation/eaccme.
Signature of the relevant application forms to exhibit at or sponsor the 13th Congress of ECCO imply that the exhibitor/sponsor has reviewed the applicable guidelines and codes, will adhere to these and accepts sole liability in case of non-compliance with the prevalent codes.
Please also refer to the ECCO’18 Exhibitor & Sponsor Prospectus for a full list of ECCO Industry Guidelines (Terms & conditions).
Other activities during the 13th Congress of ECCO
The industry is allowed to organise activities/events at the given congress dates. However, it is strictly forbidden to schedule these parallel to any official ECCO event and the core programme. “Non-industry”-associated organisations that wish to hold activities in conjunction with the 13th Congress of ECCO must submit an application to the ECCO Office.
Closed meetings of a small size (max. 20 pax) may take place during the Congress, but only invited participants may attend. These meetings shall NOT be open to the general congress participants. Please make particular effort to avoid conflicts with the scientific programme.
No activities are to be scheduled that would take delegates away from Reed Messe Wien during the official scientific programme.
ECCO will ensure that the location of industry meeting rooms will be outlined in the general congress signage and that the rooms themselves will have a sufficient level of signage. Please note that no movable-roll ups or other type of signage may be set up by industry meeting room sponsors in corridors outside the meeting room or in general areas.
ECCO will only accept responsibility for booking the meeting room at Reed Messe Wien. Thereafter, the industry meeting room sponsor is responsible for organising F&B, AV and other supplies. ECCO will share contact details of the respective suppliers in due course.
Please note that industry meetings during the 13th Congress of ECCO can only be held at Reed Messe Wien. Meetings outside the congress venue cannot be accepted.
Please contact the ECCO Office with your booking requests at firstname.lastname@example.org. Subject to availability, ECCO will offer a corresponding room and will provide an industry meeting room booking form.
European Crohn's and Colitis Organisation
Phone: +43-1-710 2242 ext. 0
Fax: +43-1-710 2242 ext. 001